24 June 2016 EMA/67161/2016 Press Office

Organisational matters CHMP meeting 20-23 June 2016

The main organisational topics addressed during the June meeting related to: •

The election of Karri Penttilä (FI) as vice-chair to the Blood Products Working Party (BPWP).



Appointment of Concepcion Prieto Yerro and Harald Enzmann as CHMP representatives to the European Medicines Agency Human Scientific Committees’ Working Party with Patients' and Consumers' Organisations (PCWP)



Appointment of Fátima Ventura as CHMP representative to the European Medicines Agency Human Scientific Committees’ Working Party with Healthcare Professionals' Organisations (HCPWP)



Information on follow-up actions and feedback from the CHMP Strategic Review and Learning meeting in Utrecht held in May.



Nomination of Ewa Bałkowiec-Iskra as observer to the Pharmacokinetics Working Party (PKWP).

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Organisational matters June 2016 - European Medicines Agency

Jun 24, 2016 - Send a question via our website www.ema.europa.eu/contact ... The main organisational topics addressed during the June meeting related to:.

70KB Sizes 1 Downloads 53 Views

Recommend Documents

monthly figures - June 2016 - European Medicines Agency - Europa EU
Jul 12, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

PDCO Monthly report 22-24 June 2016 - European Medicines Agency
Jun 30, 2016 - The PDCO adopted a positive opinion on (full) compliance check for: ... and the Paediatric Regulation is available in the Regulatory section.

July 2016 - European Medicines Agency - Europa EU
Jul 11, 2016 - EMA/COMP/451206/2016 ... Cannabidiol for treatment of graft-versus-host disease, Richardson Associates Regulatory ..... Best Regulatory.

October 2016 - European Medicines Agency - Europa EU
Nov 15, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

July 2016 - European Medicines Agency - Europa EU
Information is selected based on recommendations from consulted patients, consumers ... need one of the following: a modern web browser; a web-based news reader or a ..... person developing the medicine must submit an application to the.

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Monthly statistics report: December 2016. EMA/18823/2017. Page 2/5. Table 1. Pre-authorisation: Marketing-authorisation applications*. 2013.

Veterinary pharmacovigilance 2016 - European Medicines Agency
Feb 16, 2017 - monitoring of several centrally authorised products ..... regulatory tools within the EU that are ... Following to this, a Rapid alert was circulated.

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

monthly figures - December 2016 - European Medicines Agency
Jan 10, 2017 - Applicants can request a re-examination. The first four rows present the outcome of the evaluation before a re-examination (or a.

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.